Abstract
Prostate carcinogenesis has a hormonal basis, particularly through androgenic and estrogenic signaling. Evidence suggests that reduced expression of ER¿ and increased expression of ER¿ are associated with a microenvironment conducive to tumor progression. The modulation of these receptors thus emerges as a promising strategy in cancer therapy, constituting the primary mechanism of action …